Notable Call Options Activity in Geron - Geron (NASDAQ:GERN)

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Shares of Geron (NASDAQ: GERN) are higher on the session by 11.24%, currently trading at $2.97. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.Options traders are focusing on calls today. A short while ago the October 2011 $3.00 call traded 800 times on open interest of 149 contracts. Calls are outpacing puts today by 50 to 1. Geron Corporation is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. Geron is engaged in the discovery and development of therapeutic and diagnostic products for oncology and human embryonic stem cell therapies.

20-Year Pro Trader Reveals His "MoneyLine"

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!